Literature DB >> 6311910

Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera.

R Eberle, S W Mou.   

Abstract

Human immune sera were analyzed by an immunoblot procedure in order to identify which polypeptides of herpes simplex virus type 1 were recognized and to determine the relative concentrations of antibodies to individual viral antigens. The strongest reactivity in all immune sera examined was directed against the three major herpes simplex virus-specific glycoprotein antigens (gAB, gC, and gD) and a series of uncharacterized low-molecular-weight polypeptides. Titers of antibody to the gC and gD antigens varied among individuals and were often considerably lower than titers of antibody to the gAB antigen. Immune sera also recognized a number of nonglycosylated polypeptides, both structural and nonstructural. No consistent differences were noted between the recognition of particular viral polypeptides by sera from individuals with frequent, recurrent labial lesions and that by sera from individuals with infrequent, recurrent lesions. However, the ratio between the titer of antibody to the gAB antigen and that to the gC antigen did appear to be somewhat lower in sera from persons with a high recurrence rate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311910     DOI: 10.1093/infdis/148.3.436

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  The simian herpesvirus SA8 homologue of the herpes simplex virus gB gene: mapping, sequencing, and comparison to the HSV gB.

Authors:  R Eberle; D Black
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain-Barré syndrome.

Authors:  H J Bernsen; A M Van Loon; R F Poels; W I Verhagen; C W Frenken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

3.  Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.

Authors:  J Kahlon; F D Lakeman; M Ackermann; R J Whitley
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

4.  Humoral antibody response in patients with herpes genitalis: analysis of factors influencing the pattern of disease.

Authors:  J A Hallworth; D I Stocker; D Shariff; D Sugrue; A Buchan; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

5.  Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain.

Authors:  S Laquerre; S Person; J C Glorioso
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants.

Authors:  C T Wu; M Levine; F Homa; S L Highlander; J C Glorioso
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Application of a transformed cell line constitutively expressing HSV-1 polypeptides for the detection of HSV antibodies in human sera by an enzyme immunoassay.

Authors:  A Sivropoulou; A Vasilaki; M Arsenakis
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins.

Authors:  T C Holland; F L Homa; S D Marlin; M Levine; J Glorioso
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

9.  Simian alphaherpesviruses and their relation to the human herpes simplex viruses.

Authors:  J K Hilliard; D Black; R Eberle
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.

Authors:  E M Cantin; R Eberle; J L Baldick; B Moss; D E Willey; A L Notkins; H Openshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.